Posts Tagged ‘drug industry’

Published Drug Research Accents the Po$titive

February 9, 2022

Published Drug Research Accents the Po$titive

Scientific Method be damned, medical journals have an economic incentive for publishing papers with postive outcomes. When a drug study shows positive outcomes, pharmaceutical companies buy reprints of it in bulk to distribute it to prescribers.

Those purchases can add up to over $2 million. For journals like The Lancet ($40 annual revenue) and NEJM ($100 million/yr.), that’s huge. 41 percent of The Lancet’s 2021 income came from reprints. When it comes to drug studies, Big Phama’s thumb is firmly on the scale.


Scientific journals are incentivized to publish positive drug studies,” Annalisa Merelli, Quartz


“Why Most Published Research Findings Are False,” John P. A. Ioannidis, PLOS Medicine

Short link:

Image by Mike Licht. Download a copy here. Creative Commons license; credit Mike Licht,

Comments are welcome if they are on-topic, substantive, concise, and not boring or obscene. Comments may be edited for clarity and length.